MedPath

Effect of Equmelis” on depressio

Phase 3
Conditions
Mood disorder due to known physiological condition with depressive features
F06.31
Depression.
Registration Number
IRCT20200420047143N1
Lead Sponsor
Kermanshah University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
80
Inclusion Criteria

Age between 18 and 55
Patients who sign informed consent and cooperate during the study
Patients who their diseases are confirmed by psychiatrist and get at least score 18 on Hamilton scale

Exclusion Criteria

Patients with history of cognitive impairment in the last year
Patients with history of bipolar disorder, schizophrenia, and schizotypal disorder
Get a score of more than 2 on the Hamilton scale suicide question
Pregnant women and women who do not use contraceptives.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depression score in Hamilton scale. Timepoint: At the beginning of the study and 6 weeks after start the intervention. Method of measurement: Hamilton scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath